CVS made a big bet on Medicare. It's looking risky.

The healthcare giant cut its guidance for 2024 yet again.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...